Notices
Proposition 65 notices, documents and downloads. Search using keyword(s) or use the advanced search to include more search options.
Proposition 65 Notices
Results of first round of random selection of chemicals eligible for prioritization for consideration of carcinogenicity evaluation.
September 25, 1997 Meeting of The Science Advisory Board's Carcinogen Identification Committee (CIC): 5-Chloro-o-Toluidine And Its Strong Acid Salts; 2,4,5-Trimethylaniline And Its Strong Acid Salts; Quinoline And Its Strong Acid Salts
Notice of intent to list 18 chemicals by the authoritative bodies or "formally required" mechanisms: 1-Amino-2,4-dibromoanthraquinone, C.I. Direct Blue 15, C.I. Direct Blue 218, 3,7-Dinitrofluoranthene, 3,9-Dinitrofluoranthene, Nitrobenzene, Estropipate, Ganciclovir sodium, Amiodarone hydrochloride, Atenolol, Ethionamide, Goserelin acetate, Leuprolide acetate, Paclitaxel, Quazepam, Trimetrexate glucuronate
OEHHA has prepared draft hazard identification documents for the three chemicals and announces the availability of the documents for public comment:5-chloro-o-toluidine and its hydrochloride; 2,4,5-trimethylaniline and its hydrochloride; and quinoline.
Availability of the Procedure for Prioritizing Candidate Chemicals for Consideration Under Proposition 65 by the "State's Qualified Experts"
Availability of the Procedure for Prioritizing Candidate Chemicals for Consideration Under Proposition 65 by the "State's Qualified Experts"
Chemicals listed as known to the State to cause reproductive toxicity by the State's Qualified Experts: Arsenic (inorganic oxides) and Cadmium
Nine chemicals listed pursuant to the administrative mechanisms for listing based upon either (1) a formal identification by an authoritative body that the chemical is a carcinogen or a reproductive toxicant; or, (2) a formal requirement by a state or federal agency that the chemical be identified or labeled as causing cancer or reproductive toxicity.
Revision of notice of chemicals under consideration for possible listing via administrative mechanisms: withdrawal of Premarin (CAS No. 12126-59-9) from consideration.
Final determination on the petition to reconsider the listing of mercury and mercury compounds as known to the State to cause reproductive toxicity.
Clarification of ongoing work at OEHHA to foster consistency and harmonization of risk assessment activities across all Cal/EPA
Request for information on the reproductive and developmental toxicity of mercury and mercury compounds (excluding methyl mercury), chemicals under reconsideration for listing
Request for information on the following chemicals under consideration for listing as known to the State to cause cancer or reproductive toxicity: Trimetrexate Glucuronate, Paclitaxel,
Quazepam, Nitrobenzene, Leuprolide Acetate, Ganciclovir Sodium, Goserelin Acetate, Estropipate, Ethionamide, Atenolol, Amiodarone Hydrochloride, C.I. Direct Blue 15, 3,7-Dinitrofluoranthene, 3,9-Dinitrofluoranthene, 1-Amino-2,4-dibromoanthraquinone, C.I. Direct Blue 218, Premarin
Start of 60 day comment period for the request for information on the reproductive and developmental toxicity of mercury and mercury compounds (excluding methyl mercury).
OEHHA is soliciting information which may be relevant to the evaluation of the following chemicals under consideration for listing as known to the State to cause cancer or reproductive toxicity: Tr
In a notice dated September 27, 1996, OEHHA announced that these chemicals were under consideration for listing based on a review of information indicating that the chemicals may meet the criteria
Notice of intent to list nine chemicals via the authoritative bodies mechanism or the formally required mechanism as known to the state to cause cancer or reproductive toxicity: Nitromethane, Tetrafluoroethylene, Vinyl fluoride, Spironolactone, Stanozolol, Clarithromycin, Dihydroergotamine mesylate, Hydroxyurea, Oxymetholone
Notice of postponement of prioritization of carbamazepine and progesterone for possible consideration by the Developmental and Reproductive Toxicant Identification Committee.
Meeting of the Developmental and Reproductive Toxicant Identification Committee to consider listing inorganic arsenic and cadmium.
Request for information on chemicals under consideration for possible listing as known to the State to cause cancer: 5-chloro-ortho-toluidine and its hydrochloride (CASRN: 95-79-4); quinoline (CASRN: 91-22-5); 2,4,5-trimethylaniline and its hydrochloride (CASRN: 137-17-7).